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Continuous energy conversion is controlled by reduction–oxidation (redox) processes. NADþ and NADH
represent an important redox couple in energy metabolism. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-
oxyl (TEMPOL) is a redox-cycling nitroxide that promotes the scavenging of several reactive oxygen
species (ROS) and is reduced to hydroxylamine by NADH. TEMPOL is also involved in NADþ production in
the ascorbic acid–glutathione redox cycle. We utilized the chemical properties of TEMPOL to investigate
the effects of antioxidants and NADþ/NADH modulators on the metabolic imbalance in obese mice.
Increases in the NADþ/NADH ratio by TEMPOL ameliorated the metabolic imbalance when combined
with a dietary intervention, changing from a high-fat diet to a normal diet. Plasma levels of the super-
oxide marker dihydroethidium were higher in mice receiving the dietary intervention compared with a
control diet, but were normalized with TEMPOL consumption. These ﬁndings provide novel insights into
redox regulation in obesity.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The worldwide prevalence of obesity is increasing each year.
Obesity is associated with the risk of death from all cancers [1],
shortened lifespan and decrease of healthy years [2]. However,
effective therapeutic strategies for obesity are not known.
Obesity is a condition of increased adipose tissue mass, causing
functional abnormalities in energy metabolism. Continuous en-
ergy conversion is tightly controlled by reduction–oxidation (re-
dox) processes. NADþ and NADH represent an important redox
couple for energy metabolism [3]. Over the last decade, the role of
NADþ has become increasingly understood with discovery of
proteins, such as sirtuins, that consume NADþ and function as
metabolic regulators [4]. In recent reports, regulation of the
NADþ/NADH ratio led to increased energy metabolism [3]. Stra-
tegies for such regulation include: activation of related enzymes
such as AMP-activated protein kinase [5] and nicotinamide phos-
phoribosyl transferase [6]; providing precursors for NADþ de novon open access article under the CC
nctional Science, Faculty of
aidashi Higashi-ku, Fukuoka
hu-u.ac.jp (M. Yamato),and salvage pathways [7,8]; modulation of enzymes that consume
NADþ such as poly(ADP-ribose)polymerase and CD38 [9,10]; and
providing substrates of NADH:quinone oxidoreductase [11]. These
studies showed that increasing the NADþ/NADH ratio, including
by promoting NADH oxidation, is critical to accelerating energy
metabolism. In obese mice, the NADþ/NADH ratio was lower than
in lean mice [12], further suggesting that increasing the NADþ/
NADH ratio would be necessary for changing metabolic state to
maintain homeostasis.
In contrast, in adipose tissue and plasma, oxidative stress and
generation of reactive oxygen species (ROS) is greater in obese
mice than in lean mice [13]. To decrease oxidative stress and its
resulting tissue damage, administration of antioxidants has been
considered [14].
Both approaches have been shown to attenuate disease
symptoms, yet they are completely contradictory. While one in-
volves increasing oxidation from NADH to NADþ the other is a
process involving reduction, for example, to decrease ROS levels.
We hypothesized that obesity leads to a growing imbalance be-
tween reduction–oxidation (redox) status in the body and that
correction of this imbalance would be beneﬁcial.
Here, we proposed a strategy to increase the NADþ/NADH ratio
and decrease ROS production. To regulate redox status in the body,
we focused on a small redox-cycling nitroxide antioxidant, the
4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL). ThisBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. TEMPOL increased the NADþ/NADH ratio via ROS scavenging and the redox cycling system in vitro. (A) Schematic illustration of two pathways of NADþ generation by
TEMPOL. GR, glutathione reductase; NNT, nicotinamide nucleotide transhydrogenase. (B) Superoxide scavenging and simultaneous NADþ production in the hypoxanthine–
xanthine oxidase system. The reaction with superoxide was measured by the rate of reduction of ferricytochrome c at 550 nm. Reaction mixtures contained 120 mM
hypoxanthine, 0.005 units xanthine oxidase, 24 μM cytochrome c and 1 mM NADH in 10 mM phosphate buffer (pH 7.4) with TEMPOL (0–1 mM, as indicated in the ﬁgure). (C)
NADþ production in the AsA–GSH redox cycle. NADH oxidation was measured at 340 nm. The reaction mixture contained 1 mM ascorbic acid (AsA), 1 mM glutathione (GSH),
1 unit of GR and 0.5 mM NADH in 10 mM phosphate buffer (pH 7.4) with TEMPOL (0–1 mM). Values are means7SD (n¼4). *po0.05 and ***po0.005 compared with 0 mM.
M. Yamato et al. / Redox Biology 8 (2016) 316–322 317molecule has been reported to have two redox potential [15]. In
the oxidation process, an oxoammonium cation was generated by
the diffusion-controlled reaction of superoxide or hydroxyl radical
with the aminoxyl group of TEMPOL, and then was reduced by
NADH to the hydroxylamine [15,16]. During these reactions,
TEMPOL can both reduce ROS and oxidize NADH to NADþ . In the
reduction process, TEMPOL was directly reduced to the corre-
sponding hydroxylamine by ascorbic acid, resulting in formation of
the oxidation product dehydroascorbic acid (DHA) [17]. In this
case, DHA can increase the NADþ concentration via a redox cycling
system comprised of glutathione (GSH), NADPH and NADH [18].
We therefore assumed that TEMPOL could indirectly generate
NADþ by an NADH oxidation process via two different pathways,
involving either ROS scavenging or the AsA–GSH redox cycling
system (Fig. 1A).
In our study, we employed TEMPOL to investigate modulation
of the NADþ/NADH ratio to address metabolic imbalances in obese
mice. We examined effects of TEMPOL in mice under dietary
intervention following a high-fat diet (HFD), to assess dietary
impacts on its effectiveness.2. Materials and methods
2.1. Materials
4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL)
was from Sigma-Aldrich Japan (Tokyo, Japan). Xanthine oxidase,glutathione reductase (GR), NADþ , NADH, alcohol dehydrogenase
from yeast and malate dehydrogenase from yeast were from
Oriental Yeast Co., Ltd (Tokyo, Japan). The following were from
Wako Pure Chemical Industries (Osaka, Japan): ferricytochrome
c (from horse heart), hypoxanthine, cholesterol assay kit (Choles-
terol E test), triglyceride assay kit (Triglyceride E test), Tiron, as-
corbic acid, and glutathione. Dihydroethidium (DHE) was pur-
chased from Life Technologies Japan Ltd. (Tokyo, Japan).2.2. In vitro chemical reaction of TEMPOL
Superoxide was generated by the aerobic reaction of hypox-
anthine and xanthine oxidase in the presence of ferricytochrome
c and NADH. To estimate its reaction with superoxide, the rate of
reduction of ferricytochrome c was measured at 550 nm using a
grating-based spectrometer (SH-1000 Lab; Corona Electric Co.,
Ltd., Tokyo, Japan). This machine was equipped with a thermostat-
controlled cell for the reaction mixture, which contained 120 μM
hypoxanthine, 0.005 units xanthine oxidase, 24 μM cytochrome c
and 1 mM NADH in 10 mM phosphate buffer (pH 7.4) with TEM-
POL (0–1 mM, as indicated).
NADH oxidation was measured at 340 nm to assess effects of
TEMPOL in a redox cycling system. The reaction mixture contained
1 mM ascorbic acid (AsA), 1 mM glutathione (GSH), 1 unit GR and
0.5 mM NADH in 10 mM phosphate buffer (pH 7.4) with TEMPOL
(0–1 mM).
M. Yamato et al. / Redox Biology 8 (2016) 316–3223183. Animal experiments
C57BL/6N and 6J male mice were obtained from Kyudo Co. Ltd.
(Saga, Japan) and housed in a room with a 12 h light/dark cycle
and controlled temperature and humidity and were given free
access to food and water. After 1 week acclimation, mice were
commercially fed either a normal, or control, diet (CD; CE-2, Clea
Japan, Inc., Tokyo, Japan) or a high fat diet (HFD; HFD32, Clea Ja-
pan, Inc.). The CD was composed of crude protein (25.1%), crude fat
(4.8%), crude ﬁber (4.2%) and crude ash (6.7%), providing 343.1 kcal
of energy per 100 g. The HFD was composed of crude protein
(25.5%), crude fat (32.0%), crude ﬁber (2.9%) and crude ash (4.0%),
providing 507.6 kcal energy per 100 g.
Individual body weights were determined every 1 or 2 week
from 8–20 weeks of age. Obesity was established by feeding the
mice a HFD for 8 week. In the dietary intervention (DI) groups
mice were switched from HFD to CD. TEMPOL (30 mM) was added
to the drinking water using previously described dosing methods
[19].
At the end of the treatment schedule, mice were anesthetized
using a mixed solution of hydrochloric acid medetomidine (Kyor-
itsu Seiyaku Corporation, Tokyo, Japan), midazolam (Sandoz K.K.,
Tokyo, Japan) and butorphanol (Meiji Seika Pharma Co., Ltd, Tokyo,
Japan) under fasting conditions. Blood was collected from the in-
ferior vena cava with a heparinized syringe. For experiments
measuring biological activities, livers were removed and stored at
80 °C until analysis. Fat pads (inguinal, gonadal, and retro-
peritoneal) were dissected and weighed together. The ratio of fat
pad weight divided by body weight was calculated and expressed
as a percentage. All procedures and animal care were approved by
the Animal Care and Use Committee, Kyushu University (Fukuoka,
Japan), and performed in accordance with the Guidelines for An-
imal Experiments, Kyushu University.
3.1. Measurement of NADþ and NADH in liver tissue of mice
NADþ and NADH nucleotides were directly measured as pre-
viously described [20]. Brieﬂy, livers dissected from mice were
homogenized in 200 μL acid extraction buffer to measure NADþ or
200 μL alkali extraction buffer to measure NADH. Homogenates
were neutralized and the concentration of nucleotides was mea-
sured ﬂuorometrically (excitation wavelength: 365 nm and emis-
sion wavelength: 460 nm) after an enzymatic cycling reaction
using 5 μL of each sample. Values for both nucleotides were de-
tected within the linear range of standard curves.
3.2. Glucose tolerance test and measurement of plasma cholesterol
levels
An intraperitoneal glucose tolerance test was performed as
previously described [21]. Mice were fasted overnight and then
injected with glucose (2 g/kg body weight, i.p.). Blood was col-
lected from the tail vein at 0, 15, 30, 60 and 120 min following the
injection. Blood glucose levels were measured using a Glucose
Pilot Monitoring System (Aventir Biotech, LLC, Carlsbad, CA, USA).
Plasma was separated by centrifugation at 800 g for 15 min at
4 °C and stored at 80 °C until analysis. Plasma cholesterol levels
were determined using a commercially available assay kit.
3.3. Measurement of hepatic triglyceride levels
Liver tissue was homogenized (1:8, w-v) in a mixture of
chloroform and methanol (2:1). Lipid extracts were dried and
dissolved in 5% Triton X-100 in isopropanol. Hepatic triglyceride
levels were determined using a commercially available assay kit.3.4. DHE staining
To estimate in vivo oxidative stress, DHE staining was per-
formed as previously described with minor modiﬁcations [22].
Brieﬂy, mice were intravenously administered 0.3 mL DHE
(2.5 mg/mL in PBS) under isoﬂurane anesthesia. Two hours later,
mice were anesthetized with pentobarbital (50 mg/kg body
weight, i.p.). Blood was collected from the inferior vena cava and
plasma ﬂuorescence was measured in a ﬂuorescence reader (MTP-
810Lab, Corona Electric Co., Ltd.) at excitation and emission wa-
velengths of 518 nm and 605 nm, respectively. Livers were re-
moved, frozen immediately in an OCT compound (Tissue-Tech II;
Sakura Fine Chemical, Tokyo, Japan) and sectioned at a thickness of
10 μm on a cryostat (Sakura Finetek Japan Co., Ltd., Tokyo, Japan).
Nuclear staining was performed with DAPI (Invitrogen, Carlsbad,
CA, USA) in a dark chamber. A TE2000-U Fluorescence Microscope
(Nikon Corporation, Tokyo, Japan) was used for obtaining ﬂuor-
escence images of liver sections. The relative intensities of tissue
sections were quantiﬁed using Adobe Photoshop (Adobe Systems,
San Jose, CA, USA). The mean histogram value on the red channel
was recorded as the DHE ﬂuorescence level.
3.5. Oil red O staining
To visualize lipid droplets, Oil Red O staining was performed as
previously described [23]. The livers were ﬁxed and embedded in
an OCT compound and stored at 80 °C. The frozen tissues were
cut into 10 μm sections and placed on glass slides. The tissues
sections were stained with Oil Red O and counterstained with
hematoxylin to visualize lipid droplets.
3.6. TBARS assay
TBARS levels in the liver were used to estimate the accumula-
tion of lipid peroxidation products. Liver tissue was homogenized
(3:7, w-v) in 1.15% KCl and 5 mM 2,6-di-t-butyl-4-methylphenol
and 0.1 ml of this homogenate was mixed with reagents, to a ﬁnal
concentration of 2 mM EDTA, 7.5% acetic acid and 0.4% SDS. This
mixture was reacted with 0.3% thiobarbituric acid (Wako Pure
Chemical Industries, Osaka, Japan) in a boiling water bath for
45 min. After cooling, the chromogen was extracted in n-butanol:
pyridine (15:1, v-v). TBARS levels were calculated from the ab-
sorbances of the butanol-extracted supernatants at 532 nm.
3.7. Measurement of AsA
To measure AsA in the liver and plasma, the AsA-speciﬁc
ﬂuorophore-nitroxide probe Naph-DiPy nitroxide was used [24].
Liver tissue was homogenized in 5% metaphosphoric acid and
centrifuged at 14,000 g for 15 min. The supernatant was passed
through a 0.45 mm ﬁlter (Minisart RC4; Sartorius Stedim Biotec
GmbH, Goettingen, Germany) and analyzed for AsA content. Each
5 μL tissue or plasma sample was added to an assay solution
containing 85 μL distilled water and 10 μL probe stock solution
(500 μM in DMSO). Fluorescence was then measured at 310 and
430 nm excitation and emission wavelengths, respectively (Corona
grading microplate reader: SH-9000Lab, Corona Electric Co., Ltd.,
Ibaraki, Japan).
3.8. Statistics
All results are presented as means7SEM. Statistical data were
analyzed using the two-tailed t-test or the Tukey–Kramer test;
po0.05 was considered statistically signiﬁcant.
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To demonstrate that TEMPOL induced NADH oxidation, in-
creasing the NADþ/NADH ratio via two pathways, we utilized two
experimental models. The ﬁrst, an ROS scavenging system with
TEMPOL as a reducing agent, should result in reduction of ROS and
oxidation of NADH (Fig. 1A). Superoxide scavenging by TEMPOL,
with superoxide generated by the hypoxanthine–xanthine oxidase
system, was monitored in an assay based on ferricytochrome c
reduction. Coincident with superoxide scavenging, TEMPOL, in a
dose-dependent fashion, generated NADþ (Fig. 1B). These results
indicated that TEMPOL reduced superoxide levels and oxidized
NADH, ﬁndings consistent with previous reports [15]. In the sec-
ond system, we tested TEMPOL as an oxidizing agent, because it is
readily reduced to hydroxylamine by ascorbic acid (AsA) [17]. The
resulting oxidized form of AsA, dehydroascorbic acid (DHA), was
reportedly reduced to AsA in the presence of GSH, glutathione
reductase (GR) and NADH [18]. We found that with these sub-
strates, TEMPOL also produced NADþ in a dose-dependent man-
ner (Fig. 1C). In the absence of AsA, or GSH, GR did not oxidize
NADH to NADþ in the presence of TEMPOL (Supplemental Fig. 1).
These results suggested that TEMPOL can act via two pathways to
produce NADþ , that is, an ROS scavenging and NADH oxidation
system (ROS scavenging system) and an AsA–GSH redox cycle
(redox cycling system) (Fig. 1A).
TEMPOL was reported to prevent obesity in mice [19,25], with
one proposed mechanism being changes to the gut microbiome
[25]. Our ﬁndings suggest another potential mechanism for the
anti-obesity effects of TEMPOL, involving two different redox cy-
cling systems. We selected the diet intervention (DI) model for
obesity, in which C57BL/6N male mice were switched from a high
fat diet (HFD) to a normal control diet (CD), because weight loss
after switching to a CD was reported to be inconsistent [26,27].
This has led to considerations of a therapeutic strategy combining
diet counseling and drug treatment, with agents such as lorcaserin
[28]. Fig. 2A shows the experimental schedule. In the DI group,
mice were fed a HFD for 8 week then switched to a CD. Each
feeding group was further divided into two groups receiving water
alone or TEMPOL (30 mM) in the drinking water. HFD fed mice
developed obvious obesity (Fig. 2B). Though, body weight was
reduced in the group receiving DI and water alone, it was sig-
niﬁcantly lower in the group consuming TEMPOL (Fig. 2B). The
percentage of total body fat (inguinal, gonadal, and retro-
peritoneal) was higher in the DI than in the CD group. TEMPOL
consumption decreased the percentage of total body fat in the
mice under DI (Fig. 2C). To further characterize physiological
changes in mice in the DI/TEMPOL group, we measured the rectal
temperature at rest. The rectal temperatures of the DI/water group
were signiﬁcantly lower than those of mice on the CD. However,
mice in the DI/TEMPOL group had a normal temperature (Fig. 2D).
Glucose intolerance, higher total plasma cholesterol and trigly-
ceride levels and the intensity of Oil Red O staining in the mice
under DI were ameliorated signiﬁcantly by TEMPOL consumption
(Fig. 2E–H). Food and water intake and plasma concentrations of
TEMPOL were virtually identical in the DI/water and DI/TEMPOL
groups (Supplemental Fig. 2).
To test whether the TEMPOL associated weight loss and re-
covery to normal conditions were caused by decreased ROS levels,
we used 1,2-dihydroxy-3,5-benzenedisulfonic acid disodium salt
monohydrate (Tiron), a superoxide scavenger, as a comparison
treatment. In a previous report, Tiron signiﬁcantly attenuated
ischemia-reperfusion induced liver injury in rats [29]. Tiron sca-
venged free radicals but did not oxidize NADH (Supplementary
Fig. 3A and B). In mice under DI, with Tiron consumption, we
observed no improvements in body weight, body fat, glucose in-
tolerance or total plasma cholesterol levels over those in micegiven only water (Supplementary Fig. 3C–F). These results sug-
gested that antioxidant properties alone are not sufﬁcient to
ameliorate metabolic imbalances in obese C57BL/6N mice under
DI.
We next investigated whether TEMPOL, in addition to its an-
tioxidant effects, altered the NADþ/NADH ratio in the livers of
mice under DI. We found that TEMPOL consumption signiﬁcantly
increased the NADþ/NADH ratio (Fig. 3A) over that in the livers of
mice given only water, though the total amount of NADH was
unchanged between the groups (Fig. 3B). In the liver samples, both
the intensity of oxidized dihydroethidium (DHE), a relatively
speciﬁc marker of superoxide, were virtually identical in mice
under DI and those on the CD (Fig. 3C). However, in plasma
samples, the ﬂuorescence intensity of oxidized DHE, and the ac-
cumulation of thiobarbituric acid reactive substances (TBARS), an
index of lipid peroxidation, were much higher in the mice under
DI than in those on the CD (Fig. 3D and F). These indications of
oxidative stress were consistent with previous ﬁndings in obese
mice [13]. With TEMPOL consumption, DHE ﬂuorescence intensity
and TBARs levels returned to control values in the mice under DI
(Fig. 3D and F). These results indicated that mice under DI showed
signs of oxidative stress in the plasma, though not in the liver, and
TEMPOL improved this via its antioxidant effects.
To further characterize redox status in the liver, we estimated
antioxidant enzyme activities and AsA concentrations. Superoxide
dismutase (SOD) and glutathione peroxidase (GPx) activities in the
liver did not differ between mice fed a CD and those subjected to
DI (Supplemental Fig. 4). However, hepatic AsA was higher in the
mice under DI than in those on the CD though levels in plasma
(Fig. 3E and G). TEMPOL was present in the liver in its hydro-
xylamine form (Supplementary Fig. 2D). Therefore, TEMPOL may
modulate NADþ production through the AsA–GSH redox cycle,
becoming reduced to its hydroxylamine.
Our study did not address effects of changes in enzyme activity
and downstream related protein expression regulated by NADþ .
Therefore, to conﬁrm our interpretations and explore the me-
chanism of anti-obesity effects of TEMPOL, further experiments in
the appropriate cell and animal models will be required. TEMPOL
did not decrease body weight in C57BL/6J mice (Supplemental
Fig. 5) which do not express the nicotinamide nucleotide trans-
hydrogenase (NNT) gene [30]. NNT transfers reducing equivalents
from NADH to NADPþ , resulting in increased NADþ and NADPH
(Fig. 1A) [31]. This suggests that TEMPOL activated the redox cy-
cling system by oxidizing AsA to DHA, increasing NADþ through
NNT. Indeed, previous reports demonstrated anti-obesity effects
with TEMPOL in C3H and C57BL/6N mice [19,25], which express
the NNT genes [32]. Therefore, anti-obesity activity of TEMPOL
might be increasing NADþ through the redox cycling system, in
addition to its antioxidant effects.
In conclusion, TEMPOL showed anti-obesity activity through
two pathways, one involving direct ROS scavenging and the other
an activation of the redox cycling system, resulting in an increase
of the NADþ/NADH ratio. In mice subjected to DI, additional
consumption of TEMPOL, led to recovery of body weight and redox
state imbalances to those of normal-fed mice within a short period
of time. Thus, though the in vivo beneﬁts of antioxidants is con-
troversial, restoration of balance in the redox status of obese mice
represents a new therapeutic concept. Appropriate compounds
that, like TEMPOL, have two redox potentials enabling both re-
duction and oxidation, or combination therapy with both an an-
tioxidant and oxidant acting via different routes, might be useful
approaches for treating obesity.
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and 8 for DI groups except (C), (E) and (H) was n¼4). *po0.05, **po0.01, and ***po0.005 compared with the corresponding CD group; #po0.05 compared with the DI/
water group.
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